[HTML][HTML] The multi-kinase inhibitor midostaurin (M) prolongs survival compared with placebo (P) in combination with daunorubicin (D)/cytarabine (C) induction (ind) …
RM Stone, S Mandrekar, BL Sanford, S Geyer… - Blood, 2015 - Elsevier
Background: Midostaurin (M) is a multi-targeted small molecule FLT3 inhibitor which has
single agent activity in both internal tandem duplication (ITD) and tyrosine kinase domain …
single agent activity in both internal tandem duplication (ITD) and tyrosine kinase domain …
The Multi-Kinase Inhibitor Midostaurin (M) Prolongs Survival Compared with Placebo (P) in Combination with Daunorubicin (D)/Cytarabine (C) Induction (ind), High …
RM Stone, S Mandrekar, BL Sanford, S Geyer… - Blood, 2015 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p/>< jats: p> Background: Midostaurin (M) is a
multi-targeted small molecule FLT3 inhibitor which has single agent activity in both internal …
multi-targeted small molecule FLT3 inhibitor which has single agent activity in both internal …
The Multi-Kinase Inhibitor Midostaurin (M) Prolongs Survival Compared with Placebo (P) in Combination with Daunorubicin (D)/Cytarabine (C) Induction (ind), High …
RM Stone, S Mandrekar, BL Sanford, S Geyer… - 2015 - ashpublications.org
Background: Midostaurin (M) is a multi-targeted small molecule FLT3 inhibitor which has
single agent activity in both internal tandem duplication (ITD) and tyrosine kinase domain …
single agent activity in both internal tandem duplication (ITD) and tyrosine kinase domain …